CITrials Partners with Roche Pharmaceuticals to Develop Novel Treatment for Schizophrenia
CITrials, an advanced medical research company, is now working with Roche Pharmaceuticals to develop a novel treatment for people suffering from schizophrenia. By collaborating with a pioneer in the healthcare industry, CITrials is committed to groundbreaking scientific and technological advances that have the potential to transform the lives of people suffering from schizophrenia.
View full press release